Open for acquisition or licensing

Serodus is currently exploring options for acquisition of the Serodus Diabetic Kidney Disease pipeline

To learn more, or schedule a meeting for an initial non-confidential discussion, please contact:

Daniel Capion, Serodus Business Development
daniel.capion@serodus.com

Eva Steiness, Serodus CEO
eva.steiness@serodus.com

Send us a mail

Serodus AS

Heia 8
N-0268 Oslo
Norway

News

First name or full name

I accept that Serodus may use my e-mail to contact me with news and information

Close Menu

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings ACCEPT

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT